Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Journal of Infectious Diseases
Journal
Overview
Identity
Overview
Publication Venue For
Population-level correlation between incidence of curable sexually transmitted infections and HIV-1 among African women participating in HIV-1 pre-exposure prophylaxis trials.
2022
Predictors of Plasmodium falciparum Infection in the First Trimester Among Nulliparous Women From Kenya, Zambia, and the Democratic Republic of the Congo
. 225:2002-2010.
2022
Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
. 225:1915-1922.
2022
Prevention of Coronavirus Disease 2019 Among Older Adults Receiving Pneumococcal Conjugate Vaccine Suggests Interactions Between Streptococcus pneumoniae and Severe Acute Respiratory Syndrome Coronavirus 2 in the Respiratory Tract
. 225:1710-1720.
2022
Vaginal and Extra-Vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Population of Women Who Have Sex with Men
. 225:1261-1265.
2022
Effectiveness of pneumococcal conjugate vaccination against virus-associated lower respiratory tract infection among adults: a case-control study.
2022
T-Cell Immune Dysregulation and Mortality in Women with Human Immunodeficiency Virus
. 225:675-685.
2022
Menopause Is Associated with Immune Activation in Women with HIV
. 225:295-305.
2022
Respiratory Viral Infections and Infection Prevention Practices Among Women With Acute Respiratory Illness During Delivery Hospitalizations During the 2019-2020 Influenza Season
. 225:50-54.
2022
Differences in Vaginal Microbiota, Host Transcriptome, and Proteins in Women with Bacterial Vaginosis Are Associated with Metronidazole Treatment Response
. 224:2094-2104.
2021
Coronavirus Disease 2019 and Children
. 224:1807-1809.
2021
A Commentary on Current Diagnostic Challenges and Research Needs for Evaluating Reproductive Sequelae of Sexually Transmitted Infections
. 224:S72-S74.
2021
A Phase 1/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons with HIV-1 on Suppressive Antiretroviral Therapy
. 224:648-656.
2021
Current and Past Immunodeficiency Are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years
. 224:657-666.
2021
Host Genetic Risk Factors for Chlamydia trachomatis-Related Infertility in Women
. 224:S64-S71.
2021
Molecular Characterization of Microbes in the Female Upper Genital Tract: A Valiant Quest to "redefine" Pelvic Inflammatory Disease
. 224:S36-S38.
2021
What Can Serology Tell Us about the Burden of Infertility in Women Caused by Chlamydia?
. 224:S80-S85.
2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
. 224:S1-S21.
2021
The Other U = U: Untested and Untreated Genital Tract Inflammation in People Living with and Exposed to Human Immunodeficiency Virus
. 224:1-4.
2021
Hospitalization Rates and Causes among Persons with HIV in the United States and Canada, 2005-2015
. 223:2113-2123.
2021
Protection and risk: Male and female genital microbiota and sexually transmitted infections
. 223:S222-S235.
2021
Wave the Yellow Flag: Why We Should Prioritize Routine Human Immunodeficiency Virus and Sexually Transmitted Infection Care Now
. 223:930-932.
2021
Association between Vaginal Bacterial Microbiota and Vaginal Yeast Colonization
. 223:914-923.
2021
Inhibition of Necroptosis to Prevent Long-term Cardiac Damage during Pneumococcal Pneumonia and Invasive Disease
. 222:1882-1893.
2020
Respiratory Syncytial Virus Antivirals: Problems and Progress
. 222:1417-1421.
2020
An integrated hospital protocol for persons with injection-related infections may increase medications for opioid use disorder use but challenges remain
. 222:S499-S505.
2020
Hepatitis C among high-risk alabamians: Disease burden and screening effectiveness
. 222:S365-S375.
2020
Genital shedding of human immunodeficiency virus Type-1 (HIV) when antiretroviral therapy suppresses HIV replication in the plasma
. 222:777-786.
2020
The epidemiology of herpes zoster in immunocompetent, unvaccinated adults ≥50 years old: Incidence, complications, hospitalization, mortality, and recurrence
. 222:798-806.
2020
Pneumococci can become virulent by acquiring a new capsule from oral streptococci
. 222:372-380.
2020
Human Cytomegalovirus Infection in Women with Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity
. 221:S1-S8.
2020
Cytomegalovirus Genetic Diversity Following Primary Infection
. 221:715-720.
2020
Advances in the development of therapeutics for cytomegalovirus infections
. 221:32-44.
2020
Clinical diagnostic testing for human cytomegalovirus infections
. 221:S74-S85.
2020
Congenital cytomegalovirus infection
. 221:S9-S14.
2020
Core recommendations for antifungal stewardship: a statement of the mycoses study group education and research consortium
. 222:S175-S198.
2020
An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis
. 220:1399-1405.
2019
pfhrp2 and pfhrp3 Gene Deletions That Affect Malaria Rapid Diagnostic Tests for Plasmodium falciparum: Analysis of Archived Blood Samples From 3 African Countries
. 220:1444-1452.
2019
HLA-I Associated Adaptation Dampens CD8 T-Cell Responses in HIV Ad5-Vectored Vaccine Recipients
. 220:1620-1628.
2019
Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results from the META Longitudinal Cohort Study
. 220:1172-1177.
2019
Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults with Incident HIV-1 Infection
. 220:432-441.
2019
Tenofovir gel for prevention of herpes simplex virus type 2 acquisition: Findings from the VOICE trial
. 219:1940-1947.
2019
Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection
. 219:1398-1406.
2019
Remembering the host in tuberculosis drug development
. 219:1518-1524.
2019
Food Insecurity Is Associated With Inflammation Among Women Living With HIV
. 219:429-436.
2019
In Silico and Experimental Evaluation of Primer Sets for Species-Level Resolution of the Vaginal Microbiota Using 16S Ribosomal RNA Gene Sequencing
. 219:305-314.
2019
Effects of different doses of GEN-003, a therapeutic vaccine for genital herpes simplex virus-2, on viral shedding and lesions: Results of a randomized placebo-controlled trial
. 218:1890-1899.
2018
The control of HIV after antiretroviral medication pause (CHAMP) study: Posttreatment controllers identified from 14 clinical studies
. 218:1954-1963.
2018
Influence of Immune Priming and Egg Adaptation in the Vaccine on Antibody Responses to Circulating A(H1N1)pdm09 Viruses after Influenza Vaccination in Adults
. 218:1571-1581.
2018
Seroconversion for Cytomegalovirus Infection during Pregnancy and Fetal Infection in a Highly Seropositive Population: "the BraCHS Study"
. 218:1200-1204.
2018
Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective Study
. 218:966-978.
2018
Contribution of Breastfeeding to False-Positive Saliva Polymerase Chain Reaction for Newborn Congenital Cytomegalovirus Screening
. 217:1612-1615.
2018
Kinetics of Serological Responses in Critically Ill Patients Hospitalized with 2009 Pandemic Influenza A(H1N1) Virus Infection in Canada, 2009-2011
. 217:1078-1088.
2018
Breast milk human cytomegalovirus (CMV) viral load and the establishment of breast milk CMV-pp65-Specific CD8 T Cells in Human CMV infected mothers
. 216:1176-1179.
2017
Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children
. 216:670-677.
2017
In Memorium: William Ernest Dismukes 1939-2017.
2017
New Horizons in Mycoplasma genitalium Treatment
. 216:S412-S419.
2017
Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy
. 216:82-91.
2017
Lower Levels of Cervicovaginal Tryptophan Are Associated with Natural Clearance of Chlamydia in Women
. 215:1888-1892.
2017
Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy
. 215:1725-1733.
2017
Immunoglobulin-based investigation of spontaneous resolution of chlamydia trachomatis infection
. 215:1653-1656.
2017
Cytomegalovirus Kinetics Following Primary Infection in Healthy Women
. 215:1523-1526.
2017
Association of macrophage inflammation biomarkers with progression of subclinical carotid artery atherosclerosis in HIV-infected women and men
. 215:1352-1361.
2017
Therapeutic vaccine for Genital herpes simplex virus-2 infection: Findings from a randomized trial
. 215:856-864.
2017
TURQUOISE-I part 1b: Ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin for hepatitis C virus infection in HIV-1 coinfected patients on darunavir
. 215:599-605.
2017
Cross-reactive antibody responses to novel h5nx influenza viruses following homologous and heterologous prime-boost vaccination with a prepandemic stockpiled a(h5n1) vaccine in humans
. 216:S555-S559.
2017
Diversity in the US Infectious Diseases Workforce: Challenges for Women and Underrepresented Minorities
. 216:S606-S610.
2017
Effect of priming with seasonal influenza a(h3n2) virus on the prevalence of cross-reactive hemagglutination-inhibition antibodies to swine-origin a(h3n2) variants
. 216:S539-S547.
2017
Mild respiratory illness among young children caused by highly pathogenic avian influenza a (h5n1) virus infection in Dhaka, Bangladesh, 2011
. 216:S520-S528.
2017
Pathogenesis of Non-Zika Congenital Viral Infections
. 216:S912-S918.
2017
Sunday in the Park with Infectious Disease: Workforce Mismatch in a Colorful Universe of Possibilities
. 216:S581-S587.
2017
Intra-amniotic ureaplasma parvum-induced maternal and fetal inflammation and immune responses in rhesus macaques
. 214:1597-1604.
2016
Seasonal influenza vaccination of children induces humoral and cell-mediated immunity beyond the current season: Cross-reactivity with past and future strains
. 214:1477-1486.
2016
Influenza vaccination and antiviral therapy in pregnant women
. 214:505-506.
2016
More Easily Cultivated Than Identified: Classical Isolation with Molecular Identification of Vaginal Bacteria
. 214:S21-S28.
2016
Pathogenesis of Bacterial Vaginosis: Discussion of Current Hypotheses
. 214:S1-S5.
2016
The Vaginal Microbiome: Current Understanding and Future Directions
. 214:S36-S41.
2016
Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections
. 213:1932-1937.
2016
Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza
. 213:1180-1188.
2016
Uropathogenic Escherichia coli engages CD14-dependent signaling to enable bladder-macrophage-dependent control of acute urinary tract infection
. 213:659-668.
2016
Vaccination with heterologous HIV-1 envelope sequences and heterologous adenovirus vectors increases T-cell responses to conserved regions: HVTN 083
. 213:541-550.
2016
Pharmacological measures of treatment adherence and risk of HIV infection in the VOICE study
. 213:335-342.
2016
A newly emerged swine-origin influenza a(H3N2) variant dampens host antiviral immunity but induces potent inflammasome activation
. 212:1923-1929.
2015
Oral and vaginal tenofovir for genital herpes simplex virus type 2 shedding in immunocompetent women: A double-blind, randomized, cross-over trial
. 212:1949-1956.
2015
Breast Milk as a Potential Source of Epstein-Barr Virus Transmission Among Infants Living in a Malaria-Endemic Region of Kenya
. 212:1735-1742.
2015
Safer conception strategies for HIV-serodiscordant couples: How safe is safe enough?
. 212:1525-1528.
2015
A murine viral outgrowth assay to detect residual HIV type 1 in patients with undetectable viral loads
. 212:1387-1396.
2015
Antibody to influenza virus neuraminidase: An independent correlate of protection
. 212:1191-1199.
2015
The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2
. 212:S204-S209.
2015
Rapid and profound shifts in the vaginal microbiota following antibiotic treatment for bacterial vaginosis
. 212:793-802.
2015
Randomized trial of periodic presumptive treatment with high-dose intravaginal metronidazole and miconazole to prevent vaginal infections in HIV-negative women
. 211:1875-1882.
2015
Challenges and opportunities in developing respiratory syncytial virus therapeutics
. 211:S1-S20.
2015
Reply to hickey and forney
. 210:1683-1684.
2014
Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens
. 210:1415-1418.
2014
Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation
. 210:1155-1165.
2014
Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: A conceptual model
. 210:338-343.
2014
Basophil expansion protects against invasive pneumococcal disease in mice
. 210:14-24.
2014
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia ankara vaccines expressing HIV-1 virus-like particles
. 210:99-110.
2014
Serum antibody response to matrix protein 2 following natural infection with 2009 pandemic influenza A(H1N1) virus in humans
. 209:986-994.
2014
The scarlet H
. 209:315-317.
2014
Aging promotes b-1b cell responses to native, but not protein-conjugated, pneumococcal polysaccharides: Implications for vaccine protection in older adults
. 209:87-97.
2014
HIV-1 infection of macrophages dysregulates innate immune responses to mycobacterium tuberculosis by inhibition of interleukin-10
. 209:1055-1065.
2014
Organ pathology in the absence of bacteria?
. 209:971.
2014
Selected vaginal bacteria and risk of preterm birth: An ecological perspective
. 209:1087-1094.
2014
Transplacental transfer of azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model
. 209:898-904.
2014
Changes in measles serostatus among HIV-infected zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities
. 208:1747-1755.
2013
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA Randomized Trial): An unexpected observation
. 208:1391-1396.
2013
Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals
. 208:1240-1249.
2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248
. 208:884-891.
2013
Heterozygosity for the F508del mutation in the cystic fibrosis transmembrane conductance regulator anion channel attenuates influenza severity
. 208:780-789.
2013
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission
. 208:662-671.
2013
Spontaneous resolution of genital chlamydia trachomatis infection in women and protection from reinfection
. 207:1850-1856.
2013
Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice
. 207:1576-1584.
2013
Vaginal biofilms and bacterial vaginosis: Of mice and women
. 207:1481-1483.
2013
Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza
. 207:709-720.
2013
Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice
. 207:501-510.
2013
Immunoglobulin-specific responses to chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection
. 206:1836-1843.
2012
Mucosal escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial
. 206:1931-1935.
2012
Oseltamivir dosing in premature infants
. 206:847-850.
2012
Protecting adults from influenza: Tis the season to learn from the pandemic
. 206:803-805.
2012
Chlamydia trachomatis, mycoplasma genitalium, and trichomonas vaginalis infections in men with nongonococcal urethritis: Predictors and persistence after therapy
. 206:357-365.
2012
Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials
. 206:431-441.
2012
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults
. 206:421-430.
2012
Corallopyronin a specifically targets and depletes essential obligate wolbachia endobacteria from filarial nematodes in vivo
. 206:249-257.
2012
HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral load
. 205:1797-1805.
2012
Extravaginal reservoirs of vaginal bacteria as risk factors for incident bacterial vaginosis
. 205:1580-1588.
2012
Tuberculosis and HIV control in sub-saharan african prisons: "thinking outside the prison cell"
. 205.
2012
Local innate immune responses and influenza virus transmission and virulence in ferrets
. 205:474-485.
2012
Use of a human influenza challenge model to assess person-to-person transmission: Proof-of-concept study
. 205:35-43.
2012
Streptococcus pneumoniae serotype 9A isolates contain diverse mutations to wcjE that result in variable expression of serotype 9v-specific epitope
. 204:1585-1595.
2011
A pre-pandemic outbreak of triple-reassortant swine influenza virus infection among university students, South Dakota, 2008
. 204:1165-1171.
2011
Mixed infection and strain diversity in congenital cytomegalovirus infection
. 204:1003-1007.
2011
Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or Fusarium
. 204:942-950.
2011
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: Implications for tuberculosis screening
. 204:893-901.
2011
Establishing and sustaining a healthy vaginal environment: Analysis of data from a randomized trial of periodic presumptive treatment for vaginal infections
. 204:323-326.
2011
Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women
. 203:1534-1541.
2011
Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe
. 203:1182-1191.
2011
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles
. 203:610-619.
2011
Divergent mechanisms for passive pneumococcal resistance to β-Lactam antibiotics in the presence of Haemophilus influenzae
. 203:549-555.
2011
Impact of a functional KIR2DS4 allele on heterosexual HIV-1 transmission among discordant Zambian couples
. 203:487-495.
2011
Control of varicella disease, version 2.0
. 203:297-298.
2011
Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection
. 203:40-48.
2011
Bacterial vaginosis assessed by Gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection
. 202:1907-1915.
2010
Cytomegalovirus viruria and DNAemia in healthy seropositive women
. 202:1800-1803.
2010
Circulating Plasmacytoid Dendritic Cells in Acutely Infected Patients with Hepatitis C Virus Genotype 4 Are Normal in Number and Phenotype
. 202:1671-1675.
2010
Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus
. 202:1161-1170.
2010
Coinfection with Haemophilus influenzae promotes pneumococcal biofilm formation during experimental otitis media and impedes the progression of pneumococcal disease
. 202:1068-1075.
2010
Reply to Tarchini
. 202:979.
2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: An AIDS clinical trials group study
. 202:717-722.
2010
Oseltamivir dosing for influenza infection in premature neonates
. 202:563-566.
2010
A new pneumococcal serotype, 11E, has a variably inactivated wcjE Gene
. 202:29-38.
2010
Duration of untreated, uncomplicated chlamydia trachomatis genital infection and factors associated with chlamydia resolution: A review of human studies
. 201.
2010
A Phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis
. 201:1729-1735.
2010
Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody
. 201:1481-1487.
2010
Of ferrets and humans: Influenza pathogenesis
. 201:976-977.
2010
Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1α
. 201:866-870.
2010
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection
. 201:803-813.
2010
An evolving understanding of genital herpes pathogenesis: Is it time for our approach to therapy to change as well?
. 201:486-487.
2010
Cytomegalovirus reinfections in healthy seroimmune women
. 201:386-389.
2010
Repeated Chlamydia trachomatis genital infections in adolescent women
. 201:42-51.
2010
A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vetnam/1203/2004, in Mice
. 200:1874-1883.
2009
Bacterial vaginosis: Are we coming full circle?
. 200:1633-1635.
2009
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection
. 200:1216-1226.
2009
Role played by psrP-secY2A2 (accessory region 34) in the invasive disease potential of streptococcus pneumoniae
. 200:1180-1181.
2009
Age-associated inflammation and Toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia
. 200:546-554.
2009
Risk factors associated with subclinical human infection with avian influenza a (H5N1) virus-cambodia, 2006
. 199:1744-1752.
2009
A double-blind, placebo-controlled trial of maraviroc in treatment-experienced patients infected with non-R5 HIV-1
. 199:1638-1647.
2009
Reply to Zhang
. 199:1250-1251.
2009
Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African Americans
. 199:872-880.
2009
Streptococcus pneumoniae forms surface-attached communities in the middle ear of experimentally infected chinchillas
. 199:786-794.
2009
Distribution of genital Lactobacillus strains shared by female sex partners
. 199:680-683.
2009
Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine
. 199:320-325.
2009
Differential effects of pneumococcal vaccines against serotypes 6A and 6C
. 198:1818-1822.
2008
Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults
. 198:1345-1352.
2008
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia
. 198:1019-1027.
2008
Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block adhesion and protect mice against pneumococcal challenge
. 198:375-383.
2008
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses
. 197:1185-1188.
2008
Efavirenz-Based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts
. 197:1006-1010.
2008
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease
. 197:836-845.
2008
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects
. 197:867-870.
2008
Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women
. 197:548-554.
2008
Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006
. 196:1685-1691.
2007
Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media
. 196:1528-1536.
2007
DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza h5N1 virus infection
. 196:1493-1499.
2007
The association between Trichomonas vaginalis infection and level of vaginal lactobacilli, in nonpregnant women
. 196:1102-1107.
2007
Selective testing criteria for gonorrhea among young women screened for chlamydial infection: Contribution of race and geographic prevalence
. 196:731-737.
2007
HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages
. 195:1373-1380.
2007
Congenital cytomegalovirus infection: Impairment and immunization
. 195:767-769.
2007
Correlates of sexually transmitted infections in young women [1]
. 195:303.
2007
Functionally competent antigen-specific Cd127
hi
memory CD8
+
T cells are preserved only in HIV-infected individuals receiving early treatment
. 195:108-117.
2007
Haplotypes of IL6 and IL10 and susceptibility to human T lymphotropic virus type I infection among children
. 194:1565-1569.
2006
Prevalence of primary HIV-1 drug resistance among recently infected adolescents: A Multicenter Adolescent Medicine Trials Network for HIV/AIDS Interventions Study
. 194:1505-1509.
2006
Reply to Forney et al. [4]
. 194:1469-1470.
2006
Reply to Lawn and Wood [2]
. 194:1468.
2006
Lessons learned from reconstructing the 1918 influenza pandemic
. 194.
2006
Prevention and treatment of influenza in high-risk groups: Children, pregnant women, immunocompromised hosts, and nursing home residents
. 194.
2006
Seasonal and pandemic influenza preparedness: A global threat
. 194.
2006
Seasonal and pandemic influenza: Recommendations for preparedness in the United States
. 194.
2006
Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: The results of AIDS Clinical Trials Group 5068
. 194:623-632.
2006
Time to translate new knowledge into practice: A call for a national genital herpes control program
. 194:6-7.
2006
A persistent(ly) enigmatic ecological mystery: Bacterial vaginosis
. 193:1475-1477.
2006
Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy
. 193:1437-1440.
2006
Host immunogenetics and control of human herpesvirus-8 infection
. 193:1054-1062.
2006
The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic
. 193:905-911.
2006
Human cytomegalovirus-encoded α-chemokines exhibit high sequence variability in congenitally infected newborns
. 193:788-791.
2006
Risk factors for cervicitis among women with bacterial vaginosis
. 193:617-624.
2006
Local and systemic cytokine levels in relation to changes in vaginal flora
. 193:556-562.
2006
Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection
. 193:16-26.
2006
Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women
. 192:2039-2044.
2005
Trichomoniasis in adolescents: A marker for the lack of a public health response to the epidemic of sexually transmitted diseases in the United States
. 192:2036-2038.
2005
Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early Lyme disease
. 192:2020-2026.
2005
Association between genital tract cytomegalovirus infection and bacterial vaginosis
. 192:1727-1730.
2005
Abnormal vaginal flora as a biological risk factor for acquisition of HIV infection and sexually transmitted diseases
. 192:1315-1317.
2005
Molecular epidemiology of foodborne hepatitis A outbreaks in the United States, 2003
. 192:1323-1330.
2005
A case-control study to examine HLA haplotype associations in patients with posttreatment chronic lyme disease
. 192:1010-1013.
2005
High-dose recombinant canarypox vaccine expressing HIV-1 protein, in seronegative human subjects
. 192:1249-1259.
2005
Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults
. 192:1277-1283.
2005
Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans
. 192:791-800.
2005
Immune reconstitution after receipt of highly active antiretroviral therapy in children with advanced or progressive HIV disease and complete or partial viral load response
. 192:296-302.
2005
Changing dynamics of varicella-zoster virus infections in the 21st century: The impact of vaccination
. 191:1999-2001.
2005
Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: A potential priming strategy
. 191:1210-1215.
2005
Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents
. 191:1084-1092.
2005
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system
. 191:227-233.
2005
Influence of host genetic variation on susceptibility to HIV type 1 infection
. 191.
2005
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA Loads
. 190:1970-1978.
2004
Epidemiological and genetic correlates of incident Chlamydia trachomatis infection in North American adolescents
. 190:1723-1729.
2004
Tissue-specific contributions of pneumococcal virulence factors to pathogenesis
. 190:1661-1669.
2004
Commentary: Ch'ien LT, Cannon NJ, Charamella LJ, et al. Effect of adenine arabinoside on severe herpesvirus hominis infections in man: Preliminary report. J Infect Dis 1973; 128:658-63
. 190:1360-1367.
2004
Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen
. 190:928-934.
2004
Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis) - Resistant mutants
. 190:975-978.
2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects
. 190:886-893.
2004
Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy
. 190:271-279.
2004
Recombinant interferon-γ1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis
. 189:2185-2191.
2004
HLA-DRB1 and -DQB1 alleles and haplotypes in Zambian couples and their associations with heterosexual transmission of HIV type 1
. 189:1696-1704.
2004
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein
. 189:1221-1231.
2004
Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation
. 189:2037-2046.
2004
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials group study 359
. 189:1176-1184.
2004
Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. 1973.
. 190:1362-1367.
2004
Influence of human leukocyte antigen-B22 alleles on the course of human immunodeficiency virus type 1 infection in 3 cohorts of white men
. 188:856-863.
2003
A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease
. 188:625-634.
2003
High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: Implications for screening and urethritis management
. 188:465-468.
2003
Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae
. 188:339-348.
2003
Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: Effects on drug toxicity and on immunologic and virologic parameters
. 188:388-396.
2003
Heritability analysis of cytokines as intermediate phenotypes of tuberculosis
. 187:1679-1685.
2003
Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection
. 187:1264-1271.
2003
Immunogenic protein contaminants in pneumococcal vaccines
. 187:1019-1023.
2003
Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients
. 187:901-908.
2003
Cytomegalovirus production by infected astrocytes correlates with transforming growth factor-β release
. 187:534-541.
2003
Antigen burden is a major determinant of human immunodeficiency virus-specific CD8
+
T cell maturation state: Potential implications for therapeutic immunization
. 187:364-374.
2003
A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced ige antibodies
. 186:1261-1269.
2002
Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-α and β-chemokine receptors in congenital CMV disease
. 186:1057-1064.
2002
Durability of response to treatment among antiretroviral-experienced subjects: 48-Week results from AIDS Clinical Trials Group Protocol 359
. 186:626-633.
2002
Role of bacteriophage MAV1 as a mycoplasmal virulence factor for the development of arthritis in mice and rats
. 186:432-435.
2002
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (aids clinical trials group study 850)
. 186:198-204.
2002
Evaluation of initial CD4
+
T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings
. 185:1818-1821.
2002
Characterization of vaginal flora and bacterial vaginosis in women who have sex with women
. 185:1307-1313.
2002
Human cytomegalovirus enhances chemokine production by lipopolysaccharide-stimulated lamina propria macrophages
. 185:584-590.
2002
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure
. 185:428-438.
2002
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection
. 185:61-68.
2002
Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998
. 185:1005-1010.
2002
Quantitative culture of Chlamydia trachomatis: Relationship of inclusion-forming units produced in culture to clinical manifestations and acute inflammation in urogenital disease
. 184:1350-1354.
2001
Level of maternal antibody required to protect neonates against early-onset disease caused by group B streptococcus type Ia: A multicenter, seroepidemiology study
. 184:1022-1028.
2001
Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein B antibody transfer in guinea pigs
. 183:1547-1553.
2001
Polar production of interleukin-8 by mesothelial cells promotes the transmesothelial migration of neutrophils: Role of intercellular adhesion molecule-1
. 183:1638-1645.
2001
Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant
. 183:1688-1693.
2001
Clones of Streptococcus pneumoniae isolated from nasopharyngeal carriage and invasive disease in young children in central Tennessee
. 183:1501-1507.
2001
Immunologic profile of human immunodeficiency virus-infected patients during viral remission and relapse on antiretroviral therapy
. 183:1522-1525.
2001
Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 env, gag, and pro in combination with RGP120
. 183:563-570.
2001
Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8
+
cytotoxic T lymphocytes
. 183:368-376.
2001
Onchocerciasis in a nonendemic population: Clinical and immunologic assessment before treatment and at the time of presumed cure
. 183:512-516.
2001
Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection
. 183:401-408.
2001
Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions
. 184:879-884.
2001
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS clinical trials group protocol 373
. 183:715-721.
2001
Enterotoxin adjuvants have direct effects on T cells and antigen- presenting cells that result in either interleukin-4-dependent or - independent immune responses
. 182:180-190.
2000
Induction of acute pleural inflammation by Staphylococcus aureus. I. Cd4
+
T cells play a critical role in experimental empyema
. 181:1693-1699.
2000
A foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: First molecular traceback to deli sandwiches contaminated during preparation
. 181:1467-1470.
2000
Inflammatory cytokine mRNA expression during early and persistent Helicobacter pylori infection in nonhuman primates
. 181:783-786.
2000
Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong
. 181:344-348.
2000
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
. 182:1694-1701.
2000
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media
. 182:1146-1152.
2000
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359
. 182:1375-1384.
2000
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts
. 180:1763-1770.
1999
Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy
. 180:1851-1862.
1999
A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant
. 180:970-975.
1999
Consistent associations of HLA class I and II and transporter gene products with progression of human immunodeficiency virus type 1 infection in homosexual men
. 180:299-309.
1999
Correlation of behaviors with microbiological changes in vaginal flora
. 180:1632-1636.
1999
Effects of antigen dose and immunization regimens on antibody responses to a cytomegalovirus glycoprotein B subunit vaccine
. 180:1700-1703.
1999
Human interleukin-12 enhances interferon-γ-producing influenza-specific memory CD8
+
cytotoxic T lymphocytes
. 180:1477-1486.
1999
Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants
. 180:1569-1576.
1999
Mycobacterium-induced transmesothelial migration of monocytes into pleural space: Role of intercellular adhesion molecule-1 in tuberculous pleurisy
. 180:1616-1623.
1999
Involvement of matrix metalloproteinases in human immunodeficiency virus type 1-induced replication by clinical Mycobacterium avium isolates.
. 180:1142-1152.
1999
Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy
. 180:847-849.
1999
Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity
. 180:122-132.
1999
Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques
. 179.
1999
Mucosal immune system of the human genital tract
. 179.
1999
Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons
. 179:449-454.
1999
Molecular characterization of a globally distributed lineage of serotype 12F Streptococcus pneumoniae causing invasive disease
. 179:414-422.
1999
Herpes zoster: Risk categories for persistent pain
. 179:9-15.
1999
Asymptomatic primary cytomegalovirus infection: Virologic and immunologic features
. 180:702-707.
1999
Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997
. 180:505-508.
1999
Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities
. 178:1795-1798.
1998
Genital human papillomavirus infection in women who have sex with women
. 178:1604-1609.
1998
Identification of T cells that respond to serovar-specific regions of the Chlamydia trachomatis major outer membrane protein in persons with serovar E infection
. 178:1713-1718.
1998
Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure
. 178:1767-1775.
1998
Mycobacterium-mediated chemokine expression in pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy.
. 178:1450-1456.
1998
Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection
. 177:790-792.
1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: A meta-analysis of randomized individual patient data
. 178:349-359.
1998
Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: Effects of concomitant infections
. 178:742-751.
1998
Erratum: Retraction: A rabbit model for human cytomegalovirus-induced chorioretinal disease (The Journal of Infectious Diseases (1998) 177 (1778))
. 178:601.
1998
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1(MN) gp120, HIV-1(SF2) recombinant gp120, or both vaccines in seronegative adults
. 177:1230-1246.
1998
Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with simian immunodeficiency virus antigens in rhesus macaques
. 177:26-33.
1998
Neuropathogenesis induced by rhesus cytomegalovirus in fetal rhesus monkeys (Macaca mulatta)
. 177:446-450.
1998
Retraction: A rabbit model for human cytomeglovirus--induced chorioretinal disease (J Infect Dis 1993;168:336-44).
. 177:1778.
1998
The identification of risk factors associated with persistent pain following herpes zoster
. 178.
1998
Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy
. 177:40-47.
1998
Use of statistics and scientific inference: Odds ratios, likelihood ratio, and receiving operating characteristic curves [2] (multiple letters)
. 178:921-923.
1998
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
. 175:1080-1086.
1997
A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis
. 176:227-232.
1997
Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine
. 175:352-363.
1997
Alterations to the cell wall of Histoplasma capsulatum yeasts during infection of macrophases or epithelial cells
. 175:1538-1544.
1997
Antimicrobial resistance in Neisseria genorrhoeae in the United States, 1988-1994: The emergence of decreased susceptibility to the fluoroquinolones
. 175:1396-1403.
1997
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: Results of a phase II study
. 175:1080-1086.
1997
High incidence of Kaposi's sarcoma-associated herpesvirus and Epstein- Barr virus in tumor lesions and peripheral blood mononuclear cells from patients with Kaposi's sarcoma in Uganda
. 175:947-950.
1997
Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae
. 176:698-703.
1997
Intranasal immunization of mice with PspA (Pneumococcal surface protein A) can prevent lntranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae
. 175:839-846.
1997
A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides
. 173:113-118.
1996
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease
. 174:1162-1167.
1996
DNA polymorphisms and variant penicillin-binding proteins as evidence that relatively penicillin-resistant pneumococci in Western Canada are clonally related
. 174:884-888.
1996
Disposition of zidovudine in obese pregnant women with human immunodeficiency virus type 1 infection [4]
. 174:673.
1996
Effects of influenza A nucleoprotein on polymorphonuclear neutrophil function
. 173:279-284.
1996
Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia
. 174:141-156.
1996
Immunoregulation in onchocerciasis: Persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen
. 174:380-386.
1996
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin
. 173:627-635.
1996
Pneumococcal vaccine response in human immunodeficiency virus-infected patients
. 173:777-778.
1996
Synthesis of tumor necrosis factor-α mRNA in bronchoalveolar lavage cells from human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia
. 174:654-659.
1996
The presence or absence of active infection, not clinical status, is most closely associated with cytokine responses in lymphatic filariasis
. 173:1453-1459.
1996
The repertoire of human antibodies to the carbohydrate capsule of Streptococcus pneumoniae 6B
. 174:75-82.
1996
Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice
. 173:380-386.
1996
Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.
. 171:857-863.
1995
A randomized, double-blind, placebo-controlled trial of systemically administered interferon-α, -β, or -γ in combination with cryotherapy for the treatment of condyloma acuminatum
. 171:1081-1089.
1995
Abnormal lymphatic function in presymptomatic bancroftian filariasis
. 171:997-1001.
1995
Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection
. 171:1115-1121.
1995
Detection of herpesvirus dna by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: A prospective evaluation
. 172:1087-1090.
1995
Determining the prevalence of onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies
. 172:1414-1417.
1995
Diagnosis of herpes simplex encephalitis: Application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease
. 171:857-863.
1995
Escherichia coli endotoxin-mediated endothelial injury is modulated by glutathione ethyl ester
. 172:1119-1122.
1995
Formulation of an immunogenic human cytomegalovirus vaccine: responses in mice
. 171:18-25.
1995
Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary cmv infection in the guinea pig model
. 172:1212-1220.
1995
Safety and immunogenicity of an inactivated hepatitis a vaccine in preschool children
. 171.
1995
Virus-specific antibody responses to human cytomegalovirus (hcmv) in human immunodeficiency virus type 1-infected persons with hcmv retinitis
. 171:182-185.
1995
Association of hepatitis c virus infection with false-positive tests for syphilis
. 170:1579-1581.
1994
Epitope-specific distribution of igg subclasses against antigenic domains on glycoproteins of human cytomegalovirus
. 169:83-90.
1994
Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases
. 169:990-995.
1994
Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis
. 170:927-933.
1994
Prevalence and epidemiologic correlates of human t cell lymphotropic virus infection among intravenous drug users
. 169:962-967.
1994
Reply
. 169:937.
1994
Truly infection-free persons are rare in areas hyperendemic for african onchocerciasis
. 170:1054-1055.
1994
A Rabbit Model for Human Cytomegalovirus-Induced Chorioretinal Disease
. 168:336-344.
1993
Antibodies Induced by a Primary Cytomegalovirus Infection React with Human Herpesvirus 6 Proteins
. 168:1119-1126.
1993
Cytoadherence of plasmodium falciparum-infected erythrocytes to microvascular endothelium is regulatable by cytokines and phorbol ester
. 167:698-703.
1993
Maternal Age and Congenital Cytomegalovirus Infection: Screening of Two Diverse Newborn Populations, 1980–1990
. 168:552-556.
1993
Neonatal Screening for Congenital Cytomegalovirus Infection by Detection of Virus in Saliva
. 167:1433-1436.
1993
Oral immunization with influenza virus in biodegradable microspheres
. 167:84-90.
1993
Parvovirus Bl9-specific DNA in bone marrow from B19 arthropathy patients: Evidence for B19 virus persistence
. 167:744-748.
1993
Penile Intraepithelial Neoplasia: Clinical Presentation and an Analysis of the Physical State of Human Papillomavirus DNA
. 168:38-46.
1993
Transmission of Chlamydia trachomatis among Sex Partners Assessed by Polymerase Chain Reaction
. 168:488-492.
1993
Virus-specific antibody responses in mothers and their newborn infants with asymptomatic congenital cytomegalovirus infections
. 167:72-77.
1993
Workshop on In Vitro Neutralization of Chlamydia trachomatis: Summary of Proceedings
. 168:415-420.
1993
Evidence for a Clonal Origin of Relative Penicillin Resistance among Type 9L Pneumococci in Northwestern Canada
. 165:671-675.
1992
Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group.
. 165:450-455.
1992
Association of Biologic False-Positive Reactions for Syphilis with Human Immunodeficiency Virus Infection
. 165:1124-1126.
1992
Characterization of the Human IgG Antibody V
L
Repertoire to Haemophilus influenzae Type b Polysaccharide
. 165:S53-S56.
1992
Disseminated Herpes Zoster in the Immunocompromised Host: A Comparative Trial of Acyclovir and Vidarabine
. 165:450-455.
1992
Evolution of the Human Immunodeficiency Virus Epidemic among Patients Attending Sexually Transmitted Disease Clinics: A Decade of Experience
. 165:541-544.
1992
Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals
. 165:251-255.
1992
Infection with human t lymphotropic virus types i and ii in sexually transmitted disease clinics in Baltimore and New Orleans
. 165:920-924.
1992
Therapeutic Approaches to Varicella-Zoster Virus Infections
. 166:S51-S57.
1992
An experimental model of early central nervous system syphilis
. 163:825-829.
1991
Cytomegalovirus infection in sexually active adolescents
. 163:460-463.
1991
Epidemiologic studies of group 9 pneumococci in terms of protein type and 9N versus 9V capsular type
. 163:812-818.
1991
Evaluation of a test based on baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies
. 164:1196-1199.
1991
Herpes simplex encephalitis: The case against brain biopsy [1]
. 164:426-427.
1991
High-level viremia in adults and children infected with human immunodeficiency virus: Relation to disease stage and cd4
+
lymphocyte levels
. 164:72-80.
1991
Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults
. 164:973-975.
1991
Sexually transmitted diseases in a population of intravenous drug users: Association with seropositivity to the human immunodeficiency virus (hiv)
. 164:457-463.
1991
Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection
. 164:259-264.
1991
Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: A statistical model and its clinical implications
. 163:17-22.
1991
Use of brain biopsy for diagnostic evaluation of patients with suspected herpes simplex encephalitis: a statistical model and its clinical implications. NIAID Collaborative Antiviral Study Group.
. 163:17-22.
1991
Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.
. 162:1309-1315.
1990
Antiviral antibody responses in mothers and their newborn infants with clinical and subclinical congenital cytomegalovirus infections
. 161:214-219.
1990
Bactericidal and opsonic activity of IgGl and IgG2 anticapsular antibodies to Haemophilus influenzae type b
. 162:163-171.
1990
Behavioral contributions to acquisition of gonorrhea in patients attending an inner city sexually transmitted disease clinic
. 161:938-941.
1990
Effect of fibronectin on IgA-mediated uptake of type III group B streptococci by phagocytes
. 161:236-241.
1990
In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020. II. Studies in immunocompetent and immunosuppressed owl monkeys Aotus trivirgatus
. 162:313-321.
1990
Scedosporium inflatum: Clinical spectrum of a newly recognized pathogen
. 161:102-107.
1990
Treatment of condyloma acuminatum with three different interferon-α preparations administered parenterally: A double-blind, placebocontrolled trial
. 162:1270-1276.
1990
Seroepidemiology of group B streptococcus type III colonization at delivery.
. 159:1139-1142.
1989
Determinants Of Emergence Of Antibiotic-Resistant Neisseria Gonorrhoeae
. 159:900-907.
1989
Efficacy of Inactivated Influenza a Virus (H3N2) Vaccines Grown in Mammalian Cells or Embryonated Eggs
. 160:191-198.
1989
Host and bacterial factors associated with haemophilus influenzae type b disease in minnesota children vaccinated with type b polysaccharide vaccine
. 159:908-916.
1989
Syphilis and HIV Infection
. 160:530-534.
1989
The Efficacy of Ivermectin in the Chemotherapy of Gastrointestinal Helminthiasis in Humans
. 159:1151-1153.
1989
Aids commentary cryptococcal meningitis in patients with aids
. 157:624-628.
1988
Antibody response of the newborn after herpes simplex virus infection
. 158:925-933.
1988
Antibody to herpes simplex virus (Hsv) icp-35 proteins after hsv challenge of animals immunized with hsv subunit vaccines
. 157:1178-1186.
1988
Ceftriaxone therapy for incubating and early syphilis
. 158:881-884.
1988
Changing patterns of herpes simplex virus infection in neonates
. 158:109-116.
1988
Eggs of schistosoma mansoni stimulate endothelial cell proliferation in vitro
. 158:556-562.
1988
Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3
. 157:648-654.
1988
Primary cytomegalovirus infection in pregnancy: Comparison of antibody responses to virus-encoded proteins between women with and without intrauterine infection
. 158:917-924.
1988
The acquired immunodeficiency syndrome (AIDS) and infection with the human immunodeficiency virus (HIV)
. 158:273-285.
1988
Acute Glomerulonephritis Following Group G Streptococcal Infection
. 156:411-412.
1987
Antibody Response to Herpes Simplex Virus Glycoprotein d: Effects of Acyclovir and Relation to Recurrence
. 156:423-429.
1987
Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis
. 156:615-621.
1987
Detection of Antibodies to Herpes Simplex Virus in the Cerebrospinal Fluid of Patients with Herpes Simplex Encephalitis
. 155:38-44.
1987
Detection of antigen to herpes simplex virus in cerebrospinal fluid from patients with herpes simplex encephalitis
. 155:1172-1178.
1987
Estimated Prevalence of Ocular Toxoplasmosis and Toxocariasis in Alabama
. 156:414.
1987
Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides
. 155:1307-1314.
1987
A rabbit model of focal herpes simplex encephalitis
. 153:732-735.
1986
Isolation of cytomegalovirus from toys and hands in a day care center
. 154:527-530.
1986
Natural and vaccine-related immunity to streptococcus pneumoniae
. 154:245-256.
1986
Type-specific monoclonal antibody enhances the local phagocytic response to group B streptococcal infection
. 153:1170-1173.
1986
Treatment of systemic mycoses with ketoconazole: In vitro susceptibilities of clinical isolates of systemic and pathogenic fungi to ketoconazole
. 152:1249-1256.
1985
Serological heterogeneity of cmv isolates with a monoclonal antibody
. 152:648.
1985
Epidemiology and transmission of cytomegalovirus
. 152:243-248.
1985
Seroepidemiological studies of group B streptococcus type II
. 151:1073-1080.
1985
Antigens of treponema pallidum recognized by igg and igm antibodies during syphilis in humans
. 151:264-272.
1985
Cytomegaloviral infection and disease
. 151:772-774.
1985
Disproportionate expansion of a minor t cell subset in patients with lymphadenopathy syndrome and acquired immunodeficiency syndrome
. 151:555-559.
1985
Reply
. 151:971.
1985
The hla complex and the pathogenesis of infectious diseases
. 151:1-8.
1985
Infections caused by herpes simplex virus in the immunocompromised host: Natural history and topical acyclovir therapy
. 150:323-329.
1984
Vidarabine therapy for mucocutaneous herpes simplex virus infections in the immunocompromised host
. 149:1-8.
1984
Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections
. 147:40-46.
1983
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies.
. 147:1119-1120.
1983
Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus
. 148:953-961.
1983
Excretion of cytomegalovirus in mothers: Observations after= delivery of congenitally infected and normal infants
. 146:1-6.
1982
Herpes simplex virus encephalitis: Laboratory evaluations and their diagnostic significance
. 145:829-836.
1982
Infection with cytomegalovirus during pregnancy: Specific igm antibodies as a marker of recent primary infection
. 145:647-653.
1982
Impaired Lymphocyte Transformation Response to Cytomegalovirus and Phytohemagglutinin in Recipients of Renal Transplants: Association with Antithymocyte Globulin
. 143:259-265.
1981
Cytomegalovirus infection in patients with renal transplants: Potentiation by antithymocyte globulin and an incompatible graft
. 142:9-17.
1980
The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin
. 141:55-63.
1980
Comparative prevalence of subclinical cytomegalovirus and herpes simplex virus infections in the genital and urinary tracts of low-income, urban women
. 140:419-422.
1979
Identification of patients with increased risk of infection with herpes simplex virus after renal transplantation
. 140:487-492.
1979
Specific cell-mediated immunity in children with congenital and neonatal cytomegalovirus infection and their mothers
. 140:493-499.
1979
Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: Role of source of kidney
. 137:556-563.
1978
Treatment of infections due to Herpesvirus in humans: a critical review of the state of the art.
. 133 Suppl:A101-A108.
1976
Adenine Arabinoside for Therapy of Herpes Zoster in Immunosuppressed Patients: Preliminary Results of a Collaborative Study
. 133:A184-A191.
1976
Effect of adenine arabinoside on cytomegalovirus infections
. 130:32-39.
1974
Effect of adenine arabinoside on severe herpesvirus hominis infections in man
. 128:658-663.
1973
Inhibition of growth of candida albicans by iron-unsaturated lactoferrin: Relation to host-defense mechanisms in chronic mucocutaneous candidiasis
. 124:539-544.
1971
Identity
International Standard Serial Number (issn)
0022-1899
Electronic International Standard Serial Number (eissn)
1537-6613